VJHemOnc is committed to improving our service to you

ASH 2015 | Highlights of ASH in CLL

VJHemOnc is committed to improving our service to you

John Gribben and Stephan Stilgenbauer

At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss the recent developments occuring in CLL and how certain molecules such as Bcl-2, BTK and PI3K, have moved from being biomarkers and stratification markers to becoming targets of the disease.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter